SHANGHAI, Dec. 8, 2025 /PRNewswire/ — AsymBio, a technology-driven global Contract Development and Manufacturing Organization (CDMO) and a subsidiary of…
SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 7, 2025 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a commercial-stage biopharmaceutical company…
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company…